J&J Hit With $2.5M Verdict In 1st Philly Risperdal Trial
A Philadelphia jury slapped a Johnson & Johnson unit with $2.5 million in damages on Tuesday in the first verdict over the antipsychotic drug Risperdal's connections to abnormal breast growth in...To view the full article, register now.
Already a subscriber? Click here to view full article